Enhanced thromboxane receptor-mediated responses and impaired endothelium-dependent relaxation in human corpus cavernosum from diabetic impotent men: role of protein kinase C activity. 2006

Javier Angulo, and Pedro Cuevas, and Argentina Fernández, and Antonio Allona, and Ignacio Moncada, and Antonio Martín-Morales, and José María La Fuente, and Iñigo Sáenz de Tejada
Servicio de Histologia, Departamento de Investigación, Hospital Ramon y Cajal, Ctra. Colmenar Viejo, km 9.100, 28034 Madrid, Spain. jangulo@ibercom.com

We have evaluated the influence of protein kinase C (PKC) activity on penile smooth muscle tone in tissues from diabetic and nondiabetic men with erectile dysfunction. Human corpus cavernosum (HCC) strips were obtained from impotent diabetic and nondiabetic men at the time of penile prosthesis implantation and studied in organ chambers. Contractility responses to a prostanoid precursor, to prostanoids, and to the endothelium-dependent vasodilator acetylcholine were studied. Arachidonic acid (AA; 100 microM) caused cyclooxygenase-dependent relaxation of HCC. This relaxation was impaired in diabetic tissues and normalized by blocking thromboxane (TP) receptors with 20 nM [1S-[1alpha,2alpha(Z),3alpha,4alpha]]-7-[3-[[2-[(phenylamino)carbonyl]hydrazino]methyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid (SQ29548). Diabetes did not affect prostaglandin (PG)E(1)-induced relaxation, but it reduced relaxation induced by the PGE(1) metabolite PGE(0). This effect was related to an interaction of PGE(0) with TP receptors. Diabetic tissues had reduced endothelium-dependent relaxation, which was partially improved by SQ29548 and completely normalized by the PKC inhibitor 3-[1-[3-(dimethylaminopropyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione monohydrochloride (GF109203X; 1 microM). In HCC from nondiabetic patients, treatment with the PKC activator phorbol-12,13-dibutyrate (0.3 microM) significantly attenuated endothelium-dependent relaxation, an effect prevented by coadministration of GF109203X. Tissues from diabetic patients had enhanced sensitivity to the contractile effects of the TP receptor agonist 9,11-dideoxy-9alpha,11alpha-epoxymethano PGF(2alpha) (U46619) (EC(50) = 0.65 +/- 0.42 and 6.01 +/- 2.28 nM in diabetic and nondiabetic patients, respectively). Inhibition of PKC with 1 microM GF109203X, prevented diabetes-induced hypersensitivity to U46619-induced contractions (EC(50) = 8.55 +/- 3.12 microM). Overactivity of PKC in diabetes is responsible for enhanced contraction and reduced endothelium-dependent relaxation of HCC smooth muscle. Such alterations can result in erectile dysfunction.

UI MeSH Term Description Entries
D007172 Erectile Dysfunction The inability in the male to have a PENILE ERECTION due to psychological or organ dysfunction. Impotence,Male Impotence,Male Sexual Impotence,Dysfunction, Erectile,Impotence, Male,Impotence, Male Sexual,Sexual Impotence, Male
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008297 Male Males
D008301 Maleimides Derivatives of maleimide (the structural formula H2C2(CO)2NH) containing a pyrroledione ring where the hydrogen atom of the NH group is replaced with aliphatic or aromatic groups.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009126 Muscle Relaxation That phase of a muscle twitch during which a muscle returns to a resting position. Muscle Relaxations,Relaxation, Muscle,Relaxations, Muscle
D010413 Penis The external reproductive organ of males. It is composed of a mass of erectile tissue enclosed in three cylindrical fibrous compartments. Two of the three compartments, the corpus cavernosa, are placed side-by-side along the upper part of the organ. The third compartment below, the corpus spongiosum, houses the urethra. Glans Penis,Penis, Glans
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D004727 Endothelium A layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body. Endotheliums

Related Publications

Javier Angulo, and Pedro Cuevas, and Argentina Fernández, and Antonio Allona, and Ignacio Moncada, and Antonio Martín-Morales, and José María La Fuente, and Iñigo Sáenz de Tejada
January 2000, Urological research,
Javier Angulo, and Pedro Cuevas, and Argentina Fernández, and Antonio Allona, and Ignacio Moncada, and Antonio Martín-Morales, and José María La Fuente, and Iñigo Sáenz de Tejada
January 1992, Japanese journal of pharmacology,
Javier Angulo, and Pedro Cuevas, and Argentina Fernández, and Antonio Allona, and Ignacio Moncada, and Antonio Martín-Morales, and José María La Fuente, and Iñigo Sáenz de Tejada
October 1990, The Journal of urology,
Javier Angulo, and Pedro Cuevas, and Argentina Fernández, and Antonio Allona, and Ignacio Moncada, and Antonio Martín-Morales, and José María La Fuente, and Iñigo Sáenz de Tejada
December 2014, The aging male : the official journal of the International Society for the Study of the Aging Male,
Javier Angulo, and Pedro Cuevas, and Argentina Fernández, and Antonio Allona, and Ignacio Moncada, and Antonio Martín-Morales, and José María La Fuente, and Iñigo Sáenz de Tejada
September 2001, European journal of pharmacology,
Javier Angulo, and Pedro Cuevas, and Argentina Fernández, and Antonio Allona, and Ignacio Moncada, and Antonio Martín-Morales, and José María La Fuente, and Iñigo Sáenz de Tejada
July 1991, The Journal of urology,
Javier Angulo, and Pedro Cuevas, and Argentina Fernández, and Antonio Allona, and Ignacio Moncada, and Antonio Martín-Morales, and José María La Fuente, and Iñigo Sáenz de Tejada
January 2016, The journal of sexual medicine,
Javier Angulo, and Pedro Cuevas, and Argentina Fernández, and Antonio Allona, and Ignacio Moncada, and Antonio Martín-Morales, and José María La Fuente, and Iñigo Sáenz de Tejada
October 2016, Pharmacological reports : PR,
Javier Angulo, and Pedro Cuevas, and Argentina Fernández, and Antonio Allona, and Ignacio Moncada, and Antonio Martín-Morales, and José María La Fuente, and Iñigo Sáenz de Tejada
January 2000, Advances in experimental medicine and biology,
Javier Angulo, and Pedro Cuevas, and Argentina Fernández, and Antonio Allona, and Ignacio Moncada, and Antonio Martín-Morales, and José María La Fuente, and Iñigo Sáenz de Tejada
September 1994, Yonsei medical journal,
Copied contents to your clipboard!